Health commissioner says plan is to reduce hospitalisation and tackle long-term impact of Covid

Three Covid medicines with the potential to “change the course” of the pandemic will be authorised for mass production and use in the EU by October under a European Commission plan.

Stella Kyriakides, the commissioner for health, said such a move would reduce hospitalisation and tackle the long-term impact of Covid, with one in 10 people reporting symptoms 12 weeks after infection.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Wetherspoon’s enjoys record sales as people turn to cheaper pubs

Pub chain reports highest Easter week sales and busiest-ever Saturday The pub…

France have mastered art of winning but tireless Morocco will set new traps

‘We want to rewrite the history books,’ insists Walid Regragui as the…